|
Volumn 19, Issue 3, 2009, Pages 337-342
|
Costs and outcomes associated with IVF using recombinant FSH.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FERTILITY PROMOTING AGENT;
FOLLITROPIN;
RECOMBINANT PROTEIN;
ADULT;
ARTICLE;
COST;
DOSE RESPONSE;
ECONOMICS;
EVALUATION;
FEMALE;
FEMALE INFERTILITY;
FERTILIZATION IN VITRO;
HUMAN;
INTRACYTOPLASMIC SPERM INJECTION;
MATERNAL AGE;
METHODOLOGY;
PRACTICE GUIDELINE;
PREGNANCY;
TREATMENT OUTCOME;
ADULT;
COSTS AND COST ANALYSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FERTILITY AGENTS, FEMALE;
FERTILIZATION IN VITRO;
FOLLICLE STIMULATING HORMONE;
GUIDELINE ADHERENCE;
HUMANS;
INFERTILITY, FEMALE;
MATERNAL AGE;
PREGNANCY;
RECOMBINANT PROTEINS;
SPERM INJECTIONS, INTRACYTOPLASMIC;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 77957315726
PISSN: None
EISSN: 14726491
Source Type: Journal
DOI: 10.1016/s1472-6483(10)60167-8 Document Type: Article |
Times cited : (4)
|
References (0)
|